Company news

Faron Pharmaceuticals Oy news in 2026

Faron Pharmaceuticals Oy's news releases, calls and decks from 2026, newest first.

View company

Faron Pharmaceuticals Ltd: Approval of Share...

February 3, 2026

New Review Published in Immunotherapy Highlights the Potential for Clever-1 Inhibition with bexmarilimab to Become the Cornerstone of Next-Generation, Multi-Indication Cancer Immunotherapy

January 29, 2026

Faron Expands Bexmarilimab Program in Solid Tumors with a Randomized Phase I/II BEXAR IIT in Metastatic Soft-Tissue Sarcoma

January 27, 2026

Faron Pharmaceuticals Ltd: PDMR Dealing

January 13, 2026

← Newer news releases

Decks in 2026